Iovance Biotherapeutics (STU:2LB) Construction In Progress : €26.73 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Iovance Biotherapeutics Construction In Progress?

Iovance Biotherapeutics's quarterly construction in progress increased from Mar. 2024 (€22.05 Mil) to Jun. 2024 (€24.15 Mil) and increased from Jun. 2024 (€24.15 Mil) to Sep. 2024 (€26.73 Mil).

Iovance Biotherapeutics's annual construction in progress declined from Dec. 2021 (€31.67 Mil) to Dec. 2022 (€8.61 Mil) but then increased from Dec. 2022 (€8.61 Mil) to Dec. 2023 (€22.10 Mil).

Iovance Biotherapeutics Construction In Progress Historical Data

The historical data trend for Iovance Biotherapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iovance Biotherapeutics Construction In Progress Chart

Iovance Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

4.88

46.66

31.67

8.61

22.10

Iovance Biotherapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Construction In Progress	Get a 7-Day Free Trial															20.34	22.10	22.05	24.15	26.73

Iovance Biotherapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Iovance Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Iovance Biotherapeutics Inc (STU:2LB) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

IOVA:USA 0JDK:UK 2LB:Germany

Address

825 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.iovance.com

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Iovance Biotherapeutics Headlines

No Headlines